SecBot SecBot
6-K ·Filed Oct 8, 2026

GSK

GSK plc
NEUTRAL
Impact 1/10
Horizonimmediate Processed20d 23h ago SEC0001654954-26-008854
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine governance disclosure with no trading implications. Monitor for any future changes in board composition or committee assignments, but no immediate action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled: T+5d
GSK ▲ +5.33% at T+5d
NEUTRAL call +5.33% · α vs SPY +5.61% · entry $46.54 → $49.02
Next anchor: T+20d in 7d
Latest observation: T+11 +8.66% FF3 residual α
Entry = T+0 close
Oct 8, 2026
via day close
T+1d
-0.09%
call -0.09% · α -0.69%
$46.50
settled 20d ago
T+5d
+5.33%
call +5.33% · α +5.61%
$49.02
settled 14d ago
T+20d
Pending
in 7d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

GSK filed a 6-K disclosing that independent Non-Executive Director Wendy Becker CBE has been appointed as a Non-Executive Director of Tesco PLC, effective 1 November 2026. This is a routine disclosure of an external directorship held by an existing board member and has no material impact on GSK's operations, financials, or strategy.

Key Facts

  • Wendy Becker, an independent Non-Executive Director of GSK, was appointed as a Non-Executive Director of Tesco PLC effective 1 November 2026.
  • The disclosure is made under UK Listing Rule 6.4.9R(2).
  • No financial figures, changes to GSK's board composition, or operational updates were provided.

Financial Impact

No financial impact identified.

Risk Factors

  • None identified from this filing.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-008854
Document: 0001654954-26-008854-index-headers.html0001654954-26-008854
Document: 0001654954-26-008854-index.html0001654954-26-008854
Document: 0001654954-26-008854.txt0001654954-26-008854
60 reports for GSK
Performance horizon
47% Hit rate @ T+5 9 of 19 directional calls Went positive at some point 15 of 21 best @ T+60▲ +9.35%Jul 17, 2026
Filters
Rows
Reports for GSK, sortable and filterable
TypeNow
Oct 28, 2026
1d ago
6-K
NEUTRAL ★ 5/10
$49.07awaiting T+5awaiting T+5$48.41 (−1.35%)
Oct 26, 2026
2d ago
6-K
BULLISH ★ 5/10
$51.10awaiting T+5awaiting T+5$48.41 (−5.26%)
Oct 26, 2026
2d ago
6-K
NEUTRAL ★ 1/10
$51.10awaiting T+5awaiting T+5$48.41 (−5.26%)
Oct 26, 2026
3d ago
6-K
BULLISH ★ 5/10
$51.10awaiting T+5awaiting T+5$48.41 (−5.26%)
Oct 26, 2026
3d ago
6-K
NEUTRAL ★ 4/10
$51.10awaiting T+5awaiting T+5$48.41 (−5.26%)
Oct 21, 2026
8d ago
6-K
BULLISH ★ 7/10
$50.02 $50.94▲ +1.84%▲ +2.28%$48.41 (−3.22%)
Oct 19, 2026
9d ago
6-K
BULLISH ★ 7/10
$49.46 $51.10▲ +3.32%▲ +3.46%$48.41 (−2.12%)
Oct 19, 2026
10d ago
6-K
BULLISH ★ 6/10
$49.46 $51.10▲ +3.32%▲ +3.46%$48.41 (−2.12%)
Oct 15, 2026
14d ago
6-K
NEUTRAL ★ 1/10
$49.02 $51.21▲ +4.47%▲ +5.48%$48.41 (−1.24%)
Oct 14, 2026
14d ago
6-K
NEUTRAL ★ 1/10
$47.87 $50.02▲ +4.49%▲ +4.04%$48.41 (+1.13%)
Showing 10 of 60

US Market Status

Market Open · Closes in 4h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 8, 2026